Dabur Research

Ghaziabad, India Founded: 1979 • Age: 47 yrs
Offers preclinical studies, toxicology, discovery services, and consulting for pharmaceutical development.

About Dabur Research

Dabur Research is a Healthcare company based in Ghaziabad (India) founded in 1979. It offers preclinical studies, toxicology, discovery services, and consulting for pharmaceutical development. It operates on a B2B model. The company has 115 employees. Its Indian entity Dabur Research Foundation reported revenue of β‚Ή28.06 Cr. Dabur Research offers products and services including Discovery Services, Toxicology Services, DMPK Services, and Regulatory Consulting. Its focus areas include Biotechnology, Preclinical Research, Toxicology and Discovery Services. Its competitors include Gubra, Tigermed, BioQual, Gentronix and Shanghai Semero Biotechnology and 4 more; 3 of its 9 listed competitors have raised funding.

Company details

Dabur Research Foundation is a contract research organization based in India, specializing in preclinical biology services such as oncology, neurology, and toxicology testing. They conduct high-quality studies with strict confidentiality, tailored solutions, and global regulatory compliance. Serving pharmaceutical and biotech clients, they ensure fast timelines and expertise in areas like DMPK and safety testing, focusing on innovation and client partnerships.

Operational Areas
Key Metrics
  • Annual Revenue
    ₹28.06 Cr

    FY 2025 · +34% YoY

  • Net Profit
    ₹1.58 Cr

    FY 2025 · 6% margin

  • EBITDA
    ₹5.28 Cr

    FY 2025 · 19% margin

  • Employee Count
    115

Products & Services of Dabur Research

Dabur Research offers a comprehensive portfolio of products and services, including Discovery Services, Toxicology Services, DMPK Services, and Regulatory Consulting.

Discovery Services
Research Services

Preclinical research in therapeutic areas like oncology and neurology

Toxicology Services
Safety Testing

Testing for compound toxicity and regulatory compliance

DMPK Services
Analytical Services

Drug metabolism and pharmacokinetic studies for development

Regulatory Consulting
Consulting Services

Advice on pre-IND and global regulatory frameworks

Apps and channels of Dabur Research

Dabur Research publishes 2 mobile apps with over 50 downloads.

DRF-CRO
Google Play Tools Everyone Free
Developer: DRF Research Services
View on Google Play
DRF-CRO
App Store Utilities 17+
Developer: Dabur Research Foundation
View on App Store

Board of directors of Dabur Research Foundation (Dabur Research)

Dabur Research Foundation is the primary company behind Dabur Research. The board of Dabur Research Foundation currently have 5 directors; the longest-serving is Anand Chand Burman, appointed in 1981. 8 earlier directors have ceased.

DirectorDesignationAppointedTenureEntity
Anand Chand Burman
DIN 00056216
Director25 Aug 198145 yrs 1 moDabur Research Foundation
Pritam Das Narang
DIN 00021581
Director20 Sep 199432 yrsDabur Research Foundation
Pradip Burman
DIN 00042241
Director24 Apr 199828 yrs 5 moDabur Research Foundation
Vivek Chand Burman
DIN 00041962
Director01 Apr 199927 yrs 6 moDabur Research Foundation
Gaurav Chamaria
DIN 02328443
Director15 Dec 20232 yrs 10 moDabur Research Foundation

People of Dabur Research

11 people are tracked at Dabur Research (3 in leadership, 8 in team); the tracked headcount is 115.

NameRoleGroup
Manu Jaggi
Chief Operating OfficerLeadership
Payal Jobanputra
Associate Director - Business Development & Special ProjectsLeadership
Dr. Anu Singh
Chief Operating OfficerLeadership
Ashish Jain
Project ManagementTeam
Sachin Kumar
Research Scientist A2Team
Ashvani Tripathi
Research ScientistTeam
Karishma Chauhan
Internship TraineeTeam
Priyanka Sharma
Research Scientist IITeam
Navika Gupta
ManagerTeam
Neha Gupta
Principal Research ScientistTeam
Reena Sharma
Business ConsultantTeam
Premium access

Complete people profiles for Dabur Research

Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.

  • Full employee list
  • Team structure
  • Board tenure
  • Professional contacts

Verified entity values are shown only after access is granted.

Financials of Dabur Research

Figures of Dabur Research Foundation, the primary company behind Dabur Research, for FY 2025. Revenue was ₹28.06 Cr (+34% year on year). Net profit was ₹1.58 Cr (6% margin). EBITDA was ₹5.28 Cr (19% margin). Revenue has grown at a compounded annual rate of +3% over three years and +6% over five years.

  • ₹28.06 CrRevenue · FY 2025 · +34% YoY
  • ₹1.58 CrNet profit · 6% margin
  • ₹5.28 CrEBITDA · 19% margin
  • 115Employees (provident fund records)
  • +3%Revenue CAGR, 3 years
  • +6%Revenue CAGR, 5 years

Balance sheet, profit and loss, cash flow and ratios of Dabur Research Foundation are on its company page.

Premium access

Detailed financial statements for Dabur Research

Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.

  • Statement rows
  • Financial ratios
  • Five-year trends
  • Downloads

Verified entity values are shown only after access is granted.

Competitors of Dabur Research

Dabur Research has 9 listed competitors in our database, 3 of them funded. They include Gubra, Tigermed, BioQual, Gentronix and Shanghai Semero Biotechnology, among others.

Company NameDomainFoundedHQ LocationTotal fundingEmployeesDescription
gubra.dk2008Horsholm, Denmark––
Preclinical CRO services for NAFLD/NASH, diabetes, and obesity are provided.
tigermedgrp.com2004Hangzhou, China–15
Drug development and preclinical services are provided by Tigermed.
bioqual.com1981Rockville, United States–193
Contract research on infectious disease models is conducted.
gentronix.co.uk1999Alderley Edge, United Kingdom$3.84M1
In-vitro and in-vivo genetic toxicology screening services are provided.
simrbio.com2014Shanghai, China$20.76M–
Diversified preclinical services for brain-related disorders are provided.
aquila-bm.com2011Edinburgh, United Kingdom–489
Preclinical services in immunology, regeneration, neuroscience, and histology are provided.
gvrp.in2020Hyderabad, India–8
A platform for research and drug development services is offered.
phaxiam.com2004Lyon, France$15.8M–
Antibacterial treatments using bacteriophages are developed for resistant infections.
headlandsresearch.com2018San Francisco, United States––
Clinical research services are provided by Headlands Research globally.
Premium access

Detailed competitors of Dabur Research

The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.

  • Full competitor set
  • Operating metrics
  • Benchmarks
  • Competitive positioning

Verified entity values are shown only after access is granted.

Web traffic of Dabur Research

The website of Dabur Research (daburresearch.in) receives about 1.3K visits a month.

  • Monthly visits
    1.3K

    ▲ 19.9% vs previous month

Top companies in Toxicology

10 companies that operate in the same segment as Dabur Research (Toxicology), ranked by their profile score on The Company Check.

CompanyDescriptionFoundedLocationTotal fundingRevenueEmployees
Therapeutic solutions for food allergies are developed via antibody platforms.
2019San Francisco, California, United StatesUSD 75 M––
Therapeutics for substance use disorders, including opioid-related conditions, are developed.
2020Oakland, California, United StatesUSD 70 M––
Drug delivery solutions via single-walled carbon nanotubes are offered.
2008Houston, Texas, United StatesUSD 2.5 MUSD 5.07 M9
Non-invasive drug testing technology is developed using fingerprints.
2007Cambridge, Cambridgeshire, United KingdomUSD 25.71 M––
Provides toxicology, chemistry, and consultancy services for agrochemical industries.
2020Vapi, Gujarat, India–––
Instruments for rapid human DNA identification are developed.
2006Pleasanton, California, United StatesUSD 92.06 MUSD 22.5 B78
Oral therapies for snake bite treatment are developed.
2015Corte Madera, California, United StatesUSD 16.48 M––
Quantitative urine drug testing is provided for patient monitoring.
2011San Diego, California, United States––358
Point-of-care platforms for heavy metal toxicity diagnostics are developed.
1968Billerica, Massachusetts, United StatesUSD 34 M––
Real-time trace gas analysis solutions are delivered using SIFT-MS technology.
2002Christchurch, New ZealandUSD 11.9 MUSD 23.52 M–
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Related news about Dabur Research

Premium access

Complete news archive for Dabur Research

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Dabur Research

Dabur Research was founded in 1979.

Dabur Research is headquartered in Ghaziabad, India. It is registered at Ghaziabad, Uttar Pradesh, India.

Dabur Research has 115 employees.

The primary company behind Dabur Research, Dabur Research Foundation, reported revenue of β‚Ή28.06 Cr for FY 2025, up 34% year on year.

Dabur Research Foundation is a contract research organization based in India, specializing in preclinical biology services such as oncology, neurology, and toxicology testing. They conduct high-quality studies with strict confidentiality, tailored solutions, and global regulatory compliance. Serving pharmaceutical and biotech clients, they ensure fast timelines and expertise in areas like DMPK and safety testing, focusing on innovation and client partnerships.

Dabur Research's top competitors include PHAXIAM, Gubra and BioQual.

Dabur Research offers Discovery Services, Toxicology Services, DMPK Services, and Regulatory Consulting.

Dabur Research operates through Dabur Research Foundation.

The legal entities of Dabur Research currently have 5 directors, including Pradip Burman, Gaurav Chamaria, Anand Chand Burman and others.

Yes. Dabur Research publishes DRF-CRO and 1 more app, with over 50 downloads.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available